Head and Neck Protocol - RTOG-1216
RTOG-1216
STUDY SUSPENDED 2/26/2016
Randomized Phase II/III Trial of Surgery and Postoperative Radiation Delivered with Concurrent Cisplatin versus Docetaxel versus Docetaxel and Cetuximab for High-Risk Squamous Cell Cancer of the Head and Neck.